Osteogenesis imperfecta core NGS panel
Connective Tissue Gene Tests offers five panel options for osteogenesis imperfecta (OI) testing utilizing NextGen sequencing technology, an OI COL1A1 & COL1A2 panel, an OI core panel, a dominant OI panel, a recessive OI panel and a combined dominant and recessive OI panel. In addition to genes associated with the autosomal dominant and autosomal recessive forms of OI, the panels also contain genes for disorders included in the differential diagnosis of OI.
The Osteogenesis imperfecta core NGS panel consists of three genes: COL1A1, COL1A2 and IFITM5.
Copy number variation (CNV) analysis of the Osteogenesis imperfecta core genes is also offered as a panel. Additionally, CTGT offers a comprehensive test (both NGS and CNV panels) for these genes. Panel genes are also offered as individual sequencing and deletion/duplication tests unless otherwise indicated.
Osteogenesis imperfecta core panel
Gene | Disorder | MIM | Inheritance |
COL1A1 | Osteogenesis imperfecta, type I (OI1) Osteogenesis imperfecta, type II (OI2) Osteogenesis imperfecta, type III (OI3) Osteogenesis imperfecta, type IV (OI4) |
166200 166210 259420 166220 |
AD |
COL1A2 | Osteogenesis imperfecta, type I (OI1) Osteogenesis imperfecta, type II (OI2) Osteogenesis imperfecta, type III (OI3) Osteogenesis imperfecta, type IV (OI4) |
166200 166210 259420 166220 |
AD |
IFITM5 | Osteogenesis imperfecta, type V (OI5) | 610967 | AD |
Genes(s)
Disease Group(s)
MIM
Billing
Ordering
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. HNL Lab Medicine strongly recommends confirmation of CPT codes with third-party payors and/or the AMA. We assume no responsibility for billing errors due to reliance upon CPT codes provided by HNL Lab Medicine.